BioNeutra Global Corporation (TSXV:BGA)
Canada · Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
May 6, 2025, 1:15 PM EST
BioNeutra Global Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.8 | 1.89 | 0.72 | 0.84 | 0.93 | 0.52 |
Short-Term Investments | 0 | 0 | - | - | - | - |
Cash & Short-Term Investments | 0.8 | 1.89 | 0.72 | 0.84 | 0.93 | 0.52 |
Cash Growth | 0.60% | 161.61% | -13.90% | -10.12% | 78.51% | -65.07% |
Accounts Receivable | 1.13 | 1.18 | 1.04 | 1.71 | 1.38 | 3.24 |
Other Receivables | - | 0.04 | 0.06 | 0.02 | 0.26 | 0.06 |
Receivables | 1.13 | 1.22 | 1.1 | 1.73 | 1.64 | 3.3 |
Inventory | 2.64 | 3.29 | 7.18 | 8.02 | 7.85 | 14.81 |
Prepaid Expenses | 0.7 | 0.57 | 0.72 | 0.34 | 2.03 | 2.01 |
Total Current Assets | 5.26 | 6.97 | 9.71 | 10.93 | 12.45 | 20.64 |
Property, Plant & Equipment | 8.06 | 8.47 | 9.64 | 9.75 | 10.59 | 12.26 |
Other Intangible Assets | 0.25 | 0.32 | 0.43 | 0.4 | 0.64 | 1.13 |
Total Assets | 13.57 | 15.77 | 19.78 | 21.08 | 23.68 | 34.02 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 14.2 | 12.93 | 15.43 | 14.12 | 14.75 | 20.26 |
Current Portion of Long-Term Debt | 0.89 | 0.38 | 0.3 | 0.55 | 0.74 | 0.9 |
Current Portion of Leases | 0.04 | 0.08 | 0.07 | - | - | - |
Current Unearned Revenue | 0.07 | 0.05 | 0.13 | 0.1 | 0.12 | - |
Other Current Liabilities | - | 1.34 | 0.97 | 1 | 1 | 1.37 |
Total Current Liabilities | 15.2 | 14.78 | 16.91 | 15.78 | 16.61 | 22.53 |
Long-Term Debt | 6.61 | 7.16 | 6.53 | 6.34 | 6.33 | 6.68 |
Long-Term Leases | - | 0.02 | 0.1 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | 0.03 | 0.06 |
Total Liabilities | 21.81 | 21.96 | 23.54 | 22.12 | 22.98 | 29.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 7.55 | 7.55 | 7.55 | 7.55 | 7.55 | 7.55 |
Additional Paid-In Capital | 1.62 | 1.6 | 1.59 | 1.32 | 1.32 | 1.14 |
Retained Earnings | -18.05 | -16.05 | -13.95 | -11.02 | -8.19 | -4.49 |
Comprehensive Income & Other | 0.66 | 0.71 | 1.04 | 1.12 | 0.02 | 0.55 |
Shareholders' Equity | -8.23 | -6.19 | -3.76 | -1.03 | 0.7 | 4.75 |
Total Liabilities & Equity | 13.57 | 15.77 | 19.78 | 21.08 | 23.68 | 34.02 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 7.54 | 7.64 | 7.01 | 6.89 | 7.07 | 7.58 |
Net Cash (Debt) | -6.75 | -5.75 | -6.28 | -6.05 | -6.14 | -7.06 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.15 | -0.12 | -0.14 | -0.13 | -0.13 | -0.15 |
Filing Date Shares Outstanding | 46.45 | 46.45 | 46.45 | 46.45 | 46.45 | 46.45 |
Total Common Shares Outstanding | 46.45 | 46.45 | 46.45 | 46.45 | 46.45 | 46.45 |
Working Capital | -9.93 | -7.81 | -7.2 | -4.85 | -4.16 | -1.89 |
Book Value Per Share | -0.18 | -0.13 | -0.08 | -0.02 | 0.02 | 0.10 |
Tangible Book Value | -8.49 | -6.51 | -4.18 | -1.43 | 0.06 | 3.63 |
Tangible Book Value Per Share | -0.18 | -0.14 | -0.09 | -0.03 | 0.00 | 0.08 |
Land | - | 1.59 | 1.63 | 1.52 | - | 1.56 |
Buildings | - | 6.6 | 6.75 | 6.31 | - | 6.44 |
Machinery | - | 0.38 | 0.39 | 0.34 | - | 0.34 |